Sachit Singal, MD (@sachitsingalmd) 's Twitter Profile
Sachit Singal, MD

@sachitsingalmd

PGY-3 @BrighamMedRes @HarvardMed | @BrownMedicine '22 | @BrownUniversity '18 | Interested in Cardiology, Outcomes Research, and Medical Education

ID: 1509713168624410633

calendar_today01-04-2022 02:04:13

97 Tweet

329 Followers

263 Following

U.S. Surgeon General (@surgeon_general) 's Twitter Profile Photo

I still remember Match Day as if it was yesterday. It was a day that changed my life and led me to an extraordinary group of fellow residents who became like family. 1/3

I still remember Match Day as if it was yesterday. It was a day that changed my life and led me to an extraordinary group of fellow residents who became like family. 1/3
Ben Kenigsberg, MD (@bkenigsberg) 's Twitter Profile Photo

Are Pulmonary Artery Diastolic Pressure & Pulmonary Capillary Wedge Pressure (PCWP) related in Cardiogenic Shock? See our Critical Care Cardiology Trials Network paper in Journal of Cardiac Failure 🙏 to Alex Papolos, MD & Dave Morrow, & David Berg Jason N. Katz Sean van Diepen, Sarma Singam & CCCTN onlinejcf.com/article/S1071-…

Avinainder Singh, MD, MMSc (@avinaindersingh) 's Twitter Profile Photo

My favorite session of #ACC24 Day 1. Learning from 10!! experts how they would approach chest pain. Amazing sessions with lots of nuanced discussions.

My favorite session of #ACC24 Day 1. Learning from 10!! experts how they would approach chest pain. Amazing sessions with lots of nuanced discussions.
TIMI Study Group (@timistudygroup) 's Twitter Profile Photo

Primary results from Bridge-TIMI 73a Late Breaking Clinical Trial presented by Brian Bergmark at #ACC24 show that #olezarsen reduces #triglyceride levels by ~50% without major safety concerns. Now published in NEJM. Nicholas Marston

Primary results from Bridge-TIMI 73a Late Breaking Clinical Trial presented by <a href="/BrianBergmark/">Brian Bergmark</a> at #ACC24 show that #olezarsen reduces #triglyceride levels by ~50% without major safety concerns. Now published in <a href="/NEJM/">NEJM</a>. <a href="/marstonMD/">Nicholas Marston</a>
Robert W. Yeh (@rwyeh) 's Twitter Profile Photo

Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in NEJM today. In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days. Some thoughts on this ground breaking trial:

Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in <a href="/NEJM/">NEJM</a> today.

In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days.

Some thoughts on this ground breaking trial:
Rahul Aggarwal (@rahulaggarwalmd) 's Twitter Profile Photo

1/ Our NEW JAMA study ➡️Cardiovascular, kidney, and metabolic (CKM) diseases are intertwined ✅CKM syndrome is a newly defined disease 🚨We study how common CKM syndrome tinyurl.com/yfdjvtp4 ⭐️mentor Muthu Vaduganathan & coauthor J Ostrominski.

1/ Our NEW <a href="/JAMA_current/">JAMA</a> study

➡️Cardiovascular, kidney, and metabolic (CKM) diseases are intertwined
✅CKM syndrome is a newly defined disease
🚨We study how common CKM syndrome

tinyurl.com/yfdjvtp4

⭐️mentor <a href="/mvaduganathan/">Muthu Vaduganathan</a> &amp; coauthor J Ostrominski.
Tanvee Varma, MD (@tanveevarma) 's Twitter Profile Photo

Leaving the Global Genes #RAREHealthEquity Forum this weekend incredibly inspired and my heart full— honored to have been able to speak on a panel about clinical trial diversity 🗣️

Leaving the <a href="/GlobalGenes/">Global Genes</a> #RAREHealthEquity Forum this weekend incredibly inspired and my heart full— honored to have been able to speak on a panel about clinical trial diversity 🗣️
Tanvee Varma, MD (@tanveevarma) 's Twitter Profile Photo

Excited to share our work now in JAMA about clinical trial diversity💡📝 Congress gave the FDA the authority to require diversity action plans for clinical trials. Why does this matter? Read more at: ja.ma/4dfK5pO Barbara Bierer Andrew Hantel Dana-Farber

Excited to share our work now in <a href="/JAMA_current/">JAMA</a> about clinical trial diversity💡📝

Congress gave the FDA the authority to require diversity action plans for clinical trials. Why does this matter? 

Read more at: ja.ma/4dfK5pO 

<a href="/BarbaraBierer/">Barbara Bierer</a> <a href="/ahantel/">Andrew Hantel</a> <a href="/DanaFarber/">Dana-Farber</a>
Brigham and Women's Medicine Residents (@brighammedres) 's Twitter Profile Photo

Huge congratulations to our senior residents on a fantastic fellowship #match ! We had so much fun celebrating with you yesterday. We also wanted to congratulate all of those who accepted positions in hospital medicine and primary care - we are so proud of you!

Huge congratulations to our senior residents on a fantastic fellowship #match ! We had so much fun celebrating with you yesterday. 

We also wanted to congratulate all of those who accepted positions in hospital medicine and primary care - we are so proud of you!
Brigham and Women's Medicine Residents (@brighammedres) 's Twitter Profile Photo

Awesome M&M conference today on non-occlusive vs occlusive mesenteric #ischemia presented by Tanvee Varma, MD with expert discussants Dr. Brian Bustos, Thiago Oliveira MD, MPH, and Umberto Campia. Humbling and important learning points to remember!

Awesome M&amp;M conference today on non-occlusive vs occlusive mesenteric #ischemia presented by <a href="/TanveeVarma/">Tanvee Varma, MD</a> with expert discussants Dr. Brian Bustos, <a href="/TOliveiraMD/">Thiago Oliveira MD, MPH</a>, and <a href="/u_campia/">Umberto Campia</a>. Humbling and important learning points to remember!